Vertex Pharmaceuticals Incorporated (1VRTX)
MTA
Closed
Aug 21, 2026
Day's Range
465.5052 wk Range
321.55Overview - 1VRTX - Vertex Pharmaceuticals Incorporated
Key Statistics
Valuation
Enterprise Value
97.20B
P/E (Trailing)
‪32.13‬
PEG Ratio
‪4.03‬
Price / Sales (TTM)
‪9.50‬
Price / Book
‪6.89‬
EV / EBITDA
‪22.30‬
Profitability
Gross Margin
‪85.32%‬
Profit Margin
‪34.99%‬
Operating Margin
‪38.05%‬
Return on Assets
‪11.92%‬
Return on Equity
‪23.54%‬
Ownership
Shares Outstanding
253.34M
Float
252.68M
Held by Insiders
‪0.21%‬
Held by Institutions
‪98.13%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪428.41‬
200-Day Avg
‪397.76‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1VRTX - Vertex Pharmaceuticals Incorporated
Peers - 1VRTX - Vertex Pharmaceuticals Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+28.94%52-week change20.57P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)42.67BMarket Cap+47.15%52-week change140.57P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
- 1INCYMTAIncyte Corporation17.89BMarket Cap+33.27%52-week change16.48P/E (Trailing)‪27.70%‬Profit Margin
Profile Summary - 1VRTX - Vertex Pharmaceuticals Incorporated
About
Vertex Pharmaceuticals Incorporated is a global biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the discovery, development, and commercialization of transformative medicines for patients with serious diseases. The company's primary focus centers on cystic fibrosis, where it has…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
